Nutex Health Inc
$ 129.11
-1.13%
29 May - close price
- Market Cap 914,220,000 USD
- Current Price $ 129.11
- High / Low $ 135.50 / 126.81
- Stock P/E 9.72
- Book Value 49.81
- EPS 13.67
- Next Earning Report 2026-07-30
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.29 %
- ROE 0.54 %
- 52 Week High 193.07
- 52 Week Low 77.21
About
Nutex Health, Inc. is a technology-based healthcare services company. The company is headquartered in Houston, Texas.
Analyst Target Price
$235.67
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-04-30 | 2026-03-05 | 2025-10-22 | 2025-06-30 | 2025-05-13 | 2025-03-31 | 2024-11-08 | 2024-08-08 | 2024-05-08 | 2024-03-28 | 2023-11-09 | 2023-08-09 |
| Reported EPS | 5.74 | 1.62 | 7.76 | 5.2262 | 2.56 | 11.12 | -0.32 | -0.15 | -0.06 | -7.5 | -1.25 | -1.5 |
| Estimated EPS | 5.56 | 5.5567 | 1.81 | -5.43 | 1.62 | -0.1233 | 0.28 | -0.29 | None | -0.005 | -1.5 | -1.5 |
| Surprise | 0.18 | -3.9367 | 5.95 | 10.6562 | 0.94 | 11.2433 | -0.6 | 0.14 | 0 | -7.495 | 0.25 | 0 |
| Surprise Percentage | 3.2374% | -70.846% | 328.7293% | 196.2468% | 58.0247% | 9118.6537% | -214.2857% | 48.2759% | None% | -149900% | 16.6667% | 0% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-07-30 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 4.49 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: NUTX
2026-05-28 19:10:00
This article provides a technical analysis and stock price forecast for Nutex Health Inc (NUTX), indicating a "Strong Buy" consensus based on various technical indicators. It details moving averages, momentum indicators like RSI and MACD, and identifies key support and resistance levels for the stock.
2026-05-24 20:39:33
The article provides a financial overview of Nutex Health Inc. (NUTX), detailing its revenue breakdown, profitability margins, and a comparison with competitors. It highlights that the Hospital division is the primary revenue driver, accounting for 96.3% of total sales, and presents key metrics such as gross margin (42.37%), operating margin (37.54%), net margin (28.99%), and Return on Equity (36.84%). NUTX's performance is benchmarked against industry peers LMRI and TALK, noting its superior gross margin.
2026-05-22 05:40:21
Nutex Health Inc. (NUTX) is presented as a deeply undervalued healthcare services and technology company that focuses on micro-hospitals and population health management. Despite investor concerns, the company exhibits strong operating performance, significant free cash flow generation, and an improving balance sheet, suggesting the market may be underestimating its potential. Its low Acquirer's Multiple and high IV/P ratio point to a compelling deep-value investment opportunity within the healthcare sector.
2026-05-20 10:40:21
This article compares Nutex Health (NUTX) and HCA Healthcare (HCA) stocks, concluding that NUTX offers more upside due to superior revenue growth, better profitability, and lower valuation. While HCA's stock previously fell, NUTX demonstrates stronger fundamentals in recent periods. The analysis includes detailed financial comparisons on growth, margins, momentum, and valuation multiples.
2026-05-19 06:54:00
This article provides a price-driven analysis for Nutex Health Inc. (NASDAQ: NUTX) using AI models, suggesting choppy market conditions. It outlines three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry points, targets, and stop losses. The analysis also includes multi-timeframe signal analysis with support and resistance levels.
2026-05-14 10:10:20
This article focuses on the operating expenses (excluding the cost of goods sold) of Nutex Health Inc., traded on GETTEX under the symbol 5LF. It highlights a specific financial metric for the company, accessible through the TradingView platform. The content is primarily a data point or financial report, not a news article with narrative text.
